Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06401980
Title Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Swiss Group for Clinical Cancer Research
Indications
Therapies
Age Groups: senior | adult
Covered Countries CHE


No variant requirements are available.